Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES 简体中文 中文 हिन्दी HI
Sign Up
Log in
Black Diamond Therapeutics Inc banner

Black Diamond Therapeutics Inc
NASDAQ:BDTX

Watchlist Manager
Black Diamond Therapeutics Inc Logo
Black Diamond Therapeutics Inc
NASDAQ:BDTX
Watchlist
Price: 1.765 USD -5.11% Market Closed
Market Cap: $101.1m
Write Note Create Alert

Intrinsic Value

Is BDTX undervalued or overvalued?

See the intrinsic value estimate for Black Diamond Therapeutics Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

BDTX Intrinsic Value
LOCKED
Unlock
Today vs. history

BDTX looks undervalued.
But is it cheap by its own standards?

See how today’s valuation compares with BDTX’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor BDTX
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Intrinsic Value Locked
Margin of Safety 20% Locked
Current Price $1.77
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to BDTX

Fundamental Analysis

What Black Diamond Therapeutics Does

Biotechnology Health Care

Black Diamond Therapeutics is a biotechnology company focused on developing cancer drugs for patients whose tumors are driven by specific genetic mutations. Its main work is to discover and test small-molecule medicines that can target altered forms of cancer-related proteins, especially mutations that are hard to treat with standard drugs. The company is still a drug developer, so its value comes from building a pipeline of experimental therapies rather than selling large volumes of finished products.

Headquarters
United States of America US
Employees
21
IPO date
Jan 30, 2020
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Black Diamond Therapeutics Inc

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Ownership

BDTX Insider Trading
Buy and sell transactions by insiders

Continue BDTX Research

Summary
BDTX intrinsic value, competitors valuation, and company profile.
DCF Valuation
BDTX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BDTX stock valuation using valuation multiples.
Wall St Estimates
BDTX price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financial Statements
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BDTX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financial Statements
Discount Rate
Discover More
What is the Intrinsic Value of one BDTX stock?

The intrinsic value for Black Diamond Therapeutics Inc (BDTX) under the Base Case is hidden USD.

Is BDTX stock undervalued or overvalued?

Compared with the current market price of 1.765 USD, the stock appears hidden.

Back to Top
ALPHA SPREAD
Follow us
Join 362,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.